1. Home
  2. ALUR

as of 03-06-2026 3:27pm EST

$0.71
$0.00
-0.01%
Stocks Nasdaq

Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

Founded: 2009 Country:
United States
United States
Employees: N/A City: NATICK
Market Cap: 13.3M IPO Year: N/A
Target Price: $9.50 AVG Volume (30 days): 7.9M
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $0.65 - $4.18 Next Earning Date: N/A
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): -52.35% Revenue Growth (next year): 0.41%
P/E Ratio: N/A Index: N/A
Free Cash Flow: N/A FCF Growth: N/A

AI-Powered ALUR Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 8 days ago

AI Recommendation

hold
Model Accuracy: 77.45%
77.45%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest Allurion Technologies Inc. News

ALUR Breaking Stock News: Dive into ALUR Ticker-Specific Updates for Smart Investing

All ALUR News

Share on Social Networks: